Study objectives: To assess the incidence of fever and bacteremia after fib
eroptic bronchoscopy in immunocompetent children.
Design: Prospective study.
Patients: Immunocompetent children undergoing fiberoptic bronchoscopy betwe
en January 1997 and June 1998.
Measurements and results: Ninety-one children were included in the study. F
orty-four children (48%) developed fever within 24 h following bronchoscopy
. Bacteremia was not detected in any of the cases at the time of the fever.
Children who developed fever were younger than those who remained afebrile
(mean age, 2.4 +/- 3.6 years vs 4.2 +/- 3.7 years; p = 0.025, In the fever
group, 66% of the bronchoscopies were considered abnormal, compared to 45%
in the nonfever group (p = 0.04). Of the fever group, 40.5% of BAL fluid c
ultures had significant bacterial growth, significantly higher compared to
the nonfever group (13.2%; p = 0.006). Of the 80 patients in whom BAL was p
erformed, fever occurred in 52.9% compar ed to only 18.2% in those who did
not have BAL (p = 0.03). BAL fluid content of cell count, Lipid-laden macro
phages, and interleukin-8 were not significantly different in both groups.
In a logistic regression anal lsis, the significant predictors for developi
ng fever were positive bacterial culture (relative risk, 5.1; 95% confidenc
e interval, 1.6 to 16.4; p = 0.007) and abnormal bronchoscopic findings (re
lative risk, 3.1, 95% confidence interval, 1.2 to 8.3; p = 0.02). When age
< 2 ears was included in the model, this factor became highly significant (
relative risk, 5.01; 95% confidence interval, 1.83 to 13.75; p < 0.002).
Conclusions: Fever following fiberoptic bronchoscopy is a common event in i
mmunocompetent children and is not associated with bacteremia, Risks to dev
elop this complication are age < 2)ears, positive bacterial cultures in BAL
fluid, and abnormal bronchoscopic findings.